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 Summary
 Background: We aimed to compare the frequency of IMA (internal mammarian artery) anastomoses in right and 
left breasts in patients without breast lesions and in patients with malignant breast lesions.
 Material/Methods: A total of 100 patients with no breast lesions and a total of 100 patients with malignant breast 
lesions were included in the study. The anastomoses of IMA of right and left breasts were evaluated 
on MIP and post-contrast T1-weighted magnetic resonance imaging (MRI) sequences. Breast MRI 
scans were read by a radiologist.
 Results: In patients with no breast lesions, IMA anastomoses were found in 45% of cases, and in patients 
with malignant breast lesions, IMA anastomoses were found in 58% cases. In four patients 
with malignant lesions, ipsilateral IMA was rudimentary, and the lesion was feeding from the 
contralateral IMA.
 Conclusions: No statistically significant difference was found between patients without any breast lesions and 
patients with malignant breast lesions with respect to the frequency of IMA anastomoses in right 
and left breasts. The frequencies were higher than expected in both groups.
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The internal mammary artery (IMA) and the lateral tho-
racic artery (LTA) are the two main arteries that supply 
blood to the breasts. IMA is better known than LTA, as it is 
used for coronary revascularization grafting [1–3]. IMA has 
a critical importance for the breast tissue; it is the main 
source of blood supply for the breasts and also for breast 
tumor cells that can spread through IMA to other parts 
of the body. In our study, we investigated the presence of 
anastomoses between right and left IMAs using magnetic 
resonance imaging (MRI). We included patients with malig-
nant breast lesions and patients with no lesions in the 
breast. We aimed to investigate whether IMA anastomoses 
are more frequent in patients with breast malignancy than 
in healthy participants.
Material and Methods
This retrospective study was performed in our univer-
sity hospital (Maltepe University Hospital, Radiology 
Department) between 2013 and 2016. A total of 100 women 
who had biopsy proven malignant breast lesions on MRI 
(BIRADS 6) and a total of 100 women who had normal 
breasts on MRI (BIRADS 1) were included. Women were 
aged between 21 and 87 years. The study was approved 
by our local ethics committee, and signed consent was 
obtained from all patients. MR images of lesions were 
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evaluated by a single radiologist. IMAs were mostly ana-
lyzed on post-contrast subtraction T1-weighted sequenc-
es (T1WS). However, maximum intensity projection (MIP) 
images were also analyzed to check for the presence of 
microvascular anastomoses. Our radiologist checked IMAs 
from their origin (subclavian artery) to the branches inside 
the breasts, and looked for anastomoses between the IMAs 
of right and left breasts. The radiologist was blinded to the 
main breast lesion and to its classification (BIRADS 1 or 6). 
Before MRI, histopathological diagnoses of the lesions in 
patients with BIRADS lesions were obtained by ultrasonog-
raphy-guided tru-cut breast biopsy.
MRI was performed with a 1.5-T MR scanner (Intera, 
Philips Medical Systems, Best, The Netherlands), with a 
dedicated double-breast surface coil and patients in the 
prone position. T1-weighted fast gradient echo fat-sup-
pressed sequences (TE/TR, 2.4/4.6 ms; flip angle, 10°; FOV, 
360×360 mm2, acquired voxel size, 0.9×0.9×2.5 mm3; 
reconstructed voxel size, 0.83×0.83×2.50 mm3; total scan-
ning, time 60 s) were acquired in the axial plane before 
contrast agent administration and 0, 1, 2, 3, 4, 5, and 7 min 
after administration of contrast agent (0.1 mmol/kg of gad-
olinium diethylenetriamine pentaacetic acid (Gd-DTPA)).
Also, T2-weighted fat-suppressed spin echo sequenc-
es were acquired in the axial plane before contrast 
agent (TE/TR, 110/7548 ms; inversion delay SPAIR, 
80 ms; flip angle 90°; FOV, 380×380 mm2; acquired voxel 
size, 1.06×1.74×3.0 mm3; reconstructed voxel size, 
0.94×0.94×3.00 mm3; total scanning time, 242 s).
Exclusion criteria
•  Prior history of breast cancer and prior history of chemo-
therapy/radiotherapy on the breast or chest wall area.
•  Prior history of breast surgery (breast-conserving/radical 
mastectomy, breast augmentation etc.)
• Prior history of coronary bypass surgery
• Bilateral breast tumors
Statistical Analysis
We used the NCSS software (Number Cruncher Statistical 
System, 2007, Kaysville, Utah, USA) for statistical analy-
sis. The Pearson’s chi-squared test was used for comparison 
of qualitative variables along with descriptive statistical 
methods (frequency, ratio). The accepted limit of signifi-
cance was p<0.05.
Results
A total of 200 female patients who underwent breast MRI 
in the Radiology Department of the Maltepe University 
Hospital between the years 2013 and 2016 were enrolled in 
the study. Their mean age was 51 years (21–87 years).
One half of the patients (n=100) were category BI-RADS 1, 
and they had no mammary lesions. In 45 of these patients, 
IMA, which was examined from its point of origin until 
the branching point, anastomosed with the contralateral 
IMA. The remaining half of patients (n=100) were cat-
egory BI-RADS 6, and they had malignant breast lesions 
confirmed by histopathology. In 58 of these patients, IMA 
anastomosed with the contralateral IMA (Figures 1, 2).
Although there was no statistically significant difference 
between the two groups with respect to the frequency of 
anastomoses (p=0.066; p>0.05), patients with malignant 
lesions had a higher frequency of anastomoses (Figure 3).
Discussion
An anastomosis is a connection between blood vessels. It 
might be congenital or acquired. There are many natural 
Figure 1.  Axial maximum intensity projection (MIP, MRI) of the breast. 
A large tumor is seen in the right breast (arrowhead). The 
right IMA is giving a branch to the left IMA (arrow).
Figure 2.  Axial post-contrast T1WS subtraction MRI of the same 

















Figure 3.  Distribution of anastomoses with respect to the presence of 
a lesion. 1 – group with anastomoses, 2 – group without 
anastomoses.
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anastomoses in the human body. One of the most well-
known example is the circle of Willis. It provides com-
munication between the blood supply of the forebrain and 
hindbrain, which is essential for collateral blood flow in 
cases of internal carotid artery (ICA) stenosis or occlusion. 
Such natural anastomoses can therefore be lifesaving. Not 
all vascular structures are the same in every human being, 
and variabilities in vascular connections are commonly 
observed. One of these variations is seen in IMA, which is 
the main blood supplier of the breast. The breast is sup-
plied mainly by two arteries. The most important of these 
vascular structures is IMA – a branch of the internal tho-
racic artery, which enters the breast medially from both 
sides of the sternum. The lateral thoracic artery – a branch 
of the axillary artery, enters the breast through the outer 
half. IMAs of both breasts might be connected by an anas-
tomosis, either congenital or acquired.
The presence of benign or malignant tumor cells in the 
breast might stimulate the proliferation of the vascular 
plexus on the same side in order to increase blood sup-
ply. This process is regulated by some angiogenic activa-
tors [4,5]. If these substances and vascular support are not 
available in sufficient amounts, tumor cells might become 
necrotic or apoptotic [6,7]. Development of an anastomo-
sis within the vascular plexus might further increase blood 
supply and stimulate proliferation.
In our study, we evaluated IMAs in patients with malig-
nant breast tumors and in patients with no breast lesions. 
To our knowledge, there has been no other study focus-
ing on this topic. The frequencies of IMA anastomoses 
were not significantly different between patients with and 
without malignant breast lesions. This means that IMA of 
both breasts might have congenital or acquired anastomo-
ses that are not related to breast lesions. Detecting these 
anastomoses is significant with respect to interventional 
therapies and other treatment modalities. This phenom-
enon might also explain contralateral breast metastases 
that are observed in 10% to 15% of patients 15 years after 
treatment and even the higher proportion of longer-term 
survivors [8]. Studies have demonstrated that contralateral 
breast cancer is the most common new primary cancer in 
breast cancer patients, accounting for 30–50% of all new 
primary cancers [9–11]. Whether these cancers are prima-
ry tumors or are metastases of the existing breast cancer 
remains unclear. In a genome study, Alkner et al. confirmed 
the presence of metastases to the contralateral breast by 
showing common clonal origin [12]. Similar to lung can-
cer, metastases to the contralateral breast are considered 
as distant metastases. Due to that, breast cancer survivors 
with tumors in the contralateral breast are currently treat-
ed, in addition to unilateral mastectomy, with prophylac-
tic hormone therapy and radiotherapy [13] or contralateral 
mastectomy. These therapies have favorable short-term 
and long-term effects. Our study demonstrated a high inci-
dence of interconnections between the vascular structures 
of both breasts. In the future, obliteration of these vascu-
lar structures might be planned in high-risk patients with 
BRCA1 and BRCA2 mutations.
Furthermore, the high incidence of vascular anastomoses 
in both breasts raises questions about staging of contralat-
eral breast metastases that are currently considered as dis-
tant organ metastases. Theoretically, tumors in the inner 
breast quadrant might spread to the contralateral breast 
through IMA anastomoses much easier than to the outer 
breast quadrant of the ipsilateral breast. In view of the 
above-mentioned information and findings, awareness of 
vascular anastomoses between both breasts seems impor-
tant. Preventing the development of such anastomoses by 
obliteration of vascular plexuses might hinder metastatic 
spread.
A small study sample and lack of evaluation of the BRCA1 
and BRCA2 mutations might be considered as limitations of 
our study.
Conclusions
In our study, we observed that the frequency of IMA anas-
tomoses in right and left breasts was high in both patient 
groups (patients with no breast lesions and patients with 
malignant breast tumors). The high incidence of these anas-
tomoses provides insight into the mechanisms of metastatic 
spread to the contralateral breast. Moreover, future thera-
pies might target such anastomoses. We believe that a bet-
ter understanding of vascular anastomoses in the breast 
will play an important role in the future. To this end, fur-
ther studies with more advanced methods are needed.
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